84 related articles for article (PubMed ID: 737968)
1. [Effect of the administration of exogenous phospholipids in dyslipidemic patients].
Ravielle A; Delise P; Totaro G; Piccolo E
Clin Ter; 1978 Sep; 86(5):441-9. PubMed ID: 737968
[No Abstract] [Full Text] [Related]
2. [Long-term effect of alufibrate in various types of hyperlipidaemia (author's transl)].
Stähelin HB; Hartmann G
Dtsch Med Wochenschr; 1974 Jun; 99(26):1392-4 passim. PubMed ID: 4601124
[No Abstract] [Full Text] [Related]
3. Response of plasma lipid fractions to the administration of exogenous phospholipids.
Campanacci L; Guarnieri G; Faccini L; Bellini G
Arzneimittelforschung; 1975 Aug; 25(8):1306-8. PubMed ID: 170948
[TBL] [Abstract][Full Text] [Related]
4. [The therapeutic value of "Essential" phospholipids].
Pristautz H
MMW Munch Med Wochenschr; 1975 Apr; 117(14):583-6. PubMed ID: 806790
[TBL] [Abstract][Full Text] [Related]
5. [Action of "essential" phospholipids on plasma lipids and fatty acids in type II hyperlipoproteinemias].
Peeters H; Blaton V; Soetewey F; Declercq B; Vandamme D
Munch Med Wochenschr; 1973 Aug; 115(31):1358-62. PubMed ID: 4741079
[No Abstract] [Full Text] [Related]
6. [Effect of treatment with phospholipids on the serum lipoprotein pattern].
Bertolotto E
Pathologica; 1970; 62(913):195-9. PubMed ID: 5525306
[No Abstract] [Full Text] [Related]
7. [Studies on the effect of essential phospholipids in the essential hypertriglyceridemia].
Walther M; Unger E; Jaross W; Hanefeld M
Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:182-4. PubMed ID: 5402583
[No Abstract] [Full Text] [Related]
8. The effect of pirozadil on plasma lipids and lipoproteins in 1185 hyperlipidaemic subjects. Multicentre study in general practice in Spain.
Tapounet R; Marti Ragué I
Drugs Exp Clin Res; 1987; 13(7):447-50. PubMed ID: 3652931
[TBL] [Abstract][Full Text] [Related]
9. [Action of purified phospholipids on the serum lipid pattern].
Tralli G
Clin Ter; 1977 Mar; 80(6):545-51. PubMed ID: 862355
[No Abstract] [Full Text] [Related]
10. Lipoprotein lipid alterations with cholestyramine administration.
Jones RJ; Dobrilovic L
J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
[No Abstract] [Full Text] [Related]
11. [Preliminary studies on the effects of CoA administration on plasmatic lipids in man].
Arrigo F; Vitale D; Consolo F
Boll Soc Ital Biol Sper; 1973 Mar; 49(5):305-10. PubMed ID: 4786567
[No Abstract] [Full Text] [Related]
12. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of cinnarizine in hyperlipaemic patients.
Saba P; Galeone F; Salvadorini F; Guarguaglini M; Houben JL
G Clin Med; 1974 Aug; 55(8):586-99. PubMed ID: 4377134
[No Abstract] [Full Text] [Related]
14. [Lipid studies in a group of patients with osteonecrosis].
Roux H; Gastaut JA; Vovan L; Sedat P; Serratrice G; Recordier AM
Rev Rhum Mal Osteoartic; 1974 Jun; 41(6):393-8. PubMed ID: 4421097
[No Abstract] [Full Text] [Related]
15. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
Schwartzkopff W; Russ E
MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
[TBL] [Abstract][Full Text] [Related]
16. [Changes of plasma lipids in normal subjects in relation to age and sex. II. Total lipids, triglycerides, phospholipids, alpha and beta lipoproteic cholesterol and single NEFA (C 16 -C 18 ) in aged persons].
Bertolini AM; Santagostino A
G Gerontol; 1971 Sep; 19(9):657-67. PubMed ID: 5157318
[No Abstract] [Full Text] [Related]
17. [Lipid disorders in gout and in hyperuricemia with myalgia].
Roux H; Vovan L; Dutertre P; Serratrice G; Recordier AM
Mars Med; 1972; 109(10):609-25. PubMed ID: 4659841
[No Abstract] [Full Text] [Related]
18. [Studies on the effect of d-thyroxine in patients with increased serum lipid level].
Steger H
Wien Klin Wochenschr; 1968 Nov; 80(47):887-98. PubMed ID: 5717659
[No Abstract] [Full Text] [Related]
19. [Modification of disordered coronary and peripheral circulation using essential phospholipids].
Pristautz H; Pavek P; Klein W
Wien Med Wochenschr; 1974 Nov; 124(44):644-8. PubMed ID: 4428784
[No Abstract] [Full Text] [Related]
20. [Study of serum lipids in normal persons and patients with essential hypertension with reference to carbohydrate metabolism].
Lüthy R
Praxis; 1969 Oct; 58(43):1365-72 contd. PubMed ID: 5395158
[No Abstract] [Full Text] [Related]
[Next] [New Search]
